欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3266/001
药品名称Hydroxycarbamide Amomed
活性成分
    • hydroxycarbamide 500.0 mg
剂型Capsule, hard
上市许可持有人Amomed Pharma GmbH Nikolsdorfer Gasse 1/15-17 1050 Vienna Austria
参考成员国 - 产品名称Netherlands (NL)
Hydroxycarbamide Amomed 500 mg, capsules
互认成员国 - 产品名称
    • Austria (AT)
    • Czechia (CZ)
      Hydroxycarbamide Amomed
    • Germany (DE)
      Hydroxycarbamide Amomed 500 mg
    • Hungary (HU)
    • Croatia (HR)
    • Poland (PL)
    • Slovenia (SI)
    • Slovakia (SK)
许可日期2016/04/15
最近更新日期2016/07/21
药物ATC编码
    • L01XX05 hydroxycarbamide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase